- Home
- ISPO vs QNCX Comparison
ISPO vs QNCX Comparison
Compare ISPO & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- QNCX
- Stock Information
- Founded
- ISPO 2010
- QNCX 2012
- Country
- ISPO United States
- QNCX United States
- Employees
- ISPO N/A
- QNCX N/A
- Industry
- ISPO Blank Checks
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPO Finance
- QNCX Health Care
- Exchange
- ISPO Nasdaq
- QNCX Nasdaq
- Market Cap
- ISPO 43.1M
- QNCX 44.0M
- IPO Year
- ISPO N/A
- QNCX 2019
- Fundamental
- Price
- ISPO $3.55
- QNCX $1.02
- Analyst Decision
- ISPO
- QNCX Strong Buy
- Analyst Count
- ISPO 0
- QNCX 5
- Target Price
- ISPO N/A
- QNCX $8.00
- AVG Volume (30 Days)
- ISPO 27.9K
- QNCX 505.9K
- Earning Date
- ISPO 05-07-2025
- QNCX 05-16-2025
- Dividend Yield
- ISPO N/A
- QNCX N/A
- EPS Growth
- ISPO N/A
- QNCX N/A
- EPS
- ISPO N/A
- QNCX N/A
- Revenue
- ISPO $265,499,000.00
- QNCX N/A
- Revenue This Year
- ISPO N/A
- QNCX N/A
- Revenue Next Year
- ISPO $148.70
- QNCX N/A
- P/E Ratio
- ISPO N/A
- QNCX N/A
- Revenue Growth
- ISPO N/A
- QNCX N/A
- 52 Week Low
- ISPO $3.11
- QNCX $0.51
- 52 Week High
- ISPO $9.31
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- ISPO 47.63
- QNCX 37.79
- Support Level
- ISPO $3.15
- QNCX $0.98
- Resistance Level
- ISPO $3.65
- QNCX $1.16
- Average True Range (ATR)
- ISPO 0.28
- QNCX 0.09
- MACD
- ISPO 0.02
- QNCX 0.00
- Stochastic Oscillator
- ISPO 56.96
- QNCX 18.52
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.